ALG10B closely interacts with KCNH2 to protect it from inhibition by pharmaceuticals and thus prevent acquired long QT syndrome - interesting, as past work has identified KCNH2 genetic variation to associate with efficacy of specific antihypertensive drugs(55, 56). This evidence concerns the gene KCNH2 and acquired long QT syndrome.